Search bioRxiv⌕ Search

Biology subjects

Torre, M.

Publications and source records attributed to Torre, M..

2 recordsLinked to original sources

SEM2: A computational framework to model multiscale mechanics with subcellular elements

Modeling multiscale mechanics in shape-shifting biological tissues in embryos, traditional, or engineered cell culture platforms (organoids, organs-on-chips) is both important and challenging. In fact, it is difficult to model relevant tissue-level structural changes mediated by discrete events at the cellular and subcellular levels, such as migration and proliferation. To accomplish this, we leveraged the subcellular element modeling (SEM) method, where ensembles of coarse-grained particles interacting via empirically defined potentials are used to model individual cells while preserving cell rheology. However, an explicit treatment of multiscale mechanics in SEM was missing. Here, we introduced SEM2, an extended version of the open-source software SEM++ and LAMMPS, enabling new analyses and visualization of particle-level stress and strain. We demonstrated various functionalities of SEM2 by simulating cell creep, migration, and proliferation in scenarios that recapitulate classical and engineered cell culture platforms. For every scenario, we highlight key mechanobiology that emerges spontaneously from particle interactions and discuss recent experimental evidence as qualitative validations of our simulations. The code for SEM2 is available on GitHub at https://github.com/Synthetic-Physiology-Lab/sem2.

bioengineering↗

A Drosophila model of chemotherapy-related cognitive impairment

Chemotherapy-related cognitive impairment (CRCI) is a common adverse effect of treatment and is characterized by deficits involving multiple cognitive domains including memory. Despite the significant morbidity of CRCI and the expected increase in cancer survivors over the coming decades, the pathophysiology of CRCI remains incompletely understood, highlighting the need for new model systems to study CRCI. Given the powerful array of genetic approaches and facile high throughput screening ability in Drosophila, our goal was to validate a Drosophila model of CRCI. We administered the chemotherapeutic agents cisplatin, cyclophosphamide, and doxorubicin to adult Drosophila. Neurocognitive deficits were observed with all tested chemotherapies, especially cisplatin. We then performed histologic and immunohistochemical analysis of cisplatin-treated Drosophila tissue, demonstrating neuropathologic evidence of increased neurodegeneration, DNA damage, and oxidative stress. Thus, our Drosophila model of CRCI recapitulates clinical, radiologic, and histologic alterations reported in chemotherapy patients. Our new Drosophila model can be used for mechanistic dissection of pathways contributing to CRCI and pharmacologic screens to identify novel therapies to ameliorate CRCI. Summary StatementWe present a Drosophila model of chemotherapy-related cognitive impairment, which recapitulates neurocognitive and neuropathologic changes observed in cancer patients treated with chemotherapy.

animal behavior and cognition↗